Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial

Purpose The purpose of this study is to evaluate the clinical and radiographic success rates of RetroMTA, OrthoMTA, and ferric sulfate as pulpotomy agents in primary molars. Materials and Methods Ninety-six primary second molars from 32 children aged 5 to 9 years were enrolled in this study. The tee...

Full description

Saved in:
Bibliographic Details
Published in:European oral research 2023-12, Vol.57 (3), p.144-150
Main Authors: Yilmaz, Sila, Keles, Sultan
Format: Article
Language:English
Subjects:
Clinical trials
Iron compounds
Sulfates
Zinc oxide
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The purpose of this study is to evaluate the clinical and radiographic success rates of RetroMTA, OrthoMTA, and ferric sulfate as pulpotomy agents in primary molars. Materials and Methods Ninety-six primary second molars from 32 children aged 5 to 9 years were enrolled in this study. The teeth were randomly divided into three groups based on the pulpotomy agent used: O-MTA, R-MTA, and FS. Clinical and radiographic follow-up examinations were conducted at 3, 6, 9, and 18 months postoperatively. Results At the end of the study period, 84 teeth were evaluated. The clinical success rates were 75% for FS, 96.4% for O-MTA, and 92.8% for R-MTA groups. In the radiographic analysis, the success rates at the 18-month follow-up period were 50% for FS, 85.8% for O-MTA, and 82.2% for R-MTA groups. According to the Chi-square test and Kaplan-Meier survival analysis, there was a statistically significant difference among the success rates and survival probabilities of the groups (p
ISSN:2651-2823
2630-6158
2651-2823
DOI:10.26650/eor.2023950004